As previously demonstrated in bone tumors arising in human patients with a PRKAR1A mutation [40], tumoral osteoblasts from the Prkar1a+/− mice showed a significantly elevated level of both a total and a free PKA enzyme. Here, PRKAR1A is linked to bone neoplasm.